PharmaShots | Incisive News in 3 Shots

Subscribe Now

therapy

Mirum's Livmarli (maralixibat) Receives US FDA's Approval as the First Approved Therapy for Cholestatic Pruritus in Patients with Alagille Syndrome

Mirum's Livmarli (maralixibat) Receives US FDA's Approval as the First Approved Therapy for Cholestatic Pruritus in Patients with...

September 29, 2021

AstraZeneca and Regeneron Collaborate to Research- Develop and Commercialize Therapies for Obesity

AstraZeneca and Regeneron Collaborate to Research- Develop and Commercialize Therapies for Obesity

July 27, 2021

Innovent's Tyvyt (sintilimab) + Pemetrexed and Platinum CT Receives NMPA's Approval as 1L Therapy with Non-squamous Non-Small Cell Lung Cancer

Innovent's Tyvyt (sintilimab) + Pemetrexed and Platinum CT Receives NMPA's Approval as 1L Therapy with Non-squamous Non-Small Cell...

February 3, 2021

Innovent Reports sNDA Acceptance of Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) as 1L Therapy for Hepatocellular Carcinoma

Innovent Reports sNDA Acceptance of Tyvyt (sintilimab) + Byvasda (biosimilar- bevacizumab) as 1L Therapy for Hepatocellular Carcin...

January 13, 2021

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

December 3, 2020

ViiV Healthcare's Cabotegravir Receives US FDA's Breakthrough Therapy Designation for HIV Prevention

ViiV Healthcare's Cabotegravir Receives US FDA's Breakthrough Therapy Designation for HIV Prevention

November 18, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us